Geriatr Psychol Neuropsychiatr Vieil . 2021 Oct 5. doi: 10.1684/pnv.2021.0955
Cédric Annweiler 1, Jean-Claude Souberbielle 2
- As of Oct 24, 2021, the page had: 34 trials, 6 trial results, 27 meta-analyses and reviews, 64 observations, 36 recommendations, 55 associations, 89 speculations, 48 videos see related: Governments, HealthProblems, Hospitals, Dark Skins, 26 risk factors are ALL associated with low Vit D, Recent Virus pages Fight COVID-19 with 50K Vit D weekly Vaccines
- Annweiler on Vitamin D, quasi-experiments, and COVID-19 - July 31, 2021
- Annweiler recommendations for Vitamin D for COVID-19, etc. often start with 200,000 - June 2021
- COVID-19 mortality reduced 4X (chart looks like 2X) by large, infrequent doses of Vitamin D in France – July 2021
- French Consensus – 200,000 IU of Vitamin D if get COVID-19 – Dec 22, 2020
- Residents of a Nursing Home who choose monthly Vitamin D had 4X fewer COVID-19 deaths – Nov 2, 2020
- Hill's Criteria indicates that COVID-19 will be treated by Vitamin D - Annweiler June 8 2020
- French National Academy recommended 100,000 IU of Vitamin D to elderly to fight COVID-19 - May 2020
After 12 months of viral circulation, the SARS-CoV-2 has infected millions of people around the world, leaving hundreds of thousands dead. Given the lack of effective therapy and vaccination against COVID-19, focusing on the immediate repurposing of existing drugs gives some hope of curbing the pandemic.
Vitamin D is a possible candidate drug which is discussed in a high number of publications.
Randomised clinical trials have shown that vitamin D supplementation significantly reduces the risk of respiratory infections.
There is also a great deal of evidence that hypovitaminosis D is an independent (and easily modifiable) risk factor for severe forms of COVID-19 and death.
Vitamin D supplementation is a simple, safe and inexpensive measure, which is effective in correcting hypovitaminosis D, present in 40-50% of the French population and in more than 80% of adults with COVID-19.
In this position paper, we propose simple regimens (adapted to the pharmaceutical forms currently available in France) for vitamin D supplementation in adults with or without COVID-19.